GB0615814D0 - Medicament - Google Patents

Medicament

Info

Publication number
GB0615814D0
GB0615814D0 GBGB0615814.1A GB0615814A GB0615814D0 GB 0615814 D0 GB0615814 D0 GB 0615814D0 GB 0615814 A GB0615814 A GB 0615814A GB 0615814 D0 GB0615814 D0 GB 0615814D0
Authority
GB
United Kingdom
Prior art keywords
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0615814.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinclair Pharmaceuticals Ltd
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Priority to GBGB0615814.1A priority Critical patent/GB0615814D0/en
Publication of GB0615814D0 publication Critical patent/GB0615814D0/en
Priority to PCT/GB2007/002963 priority patent/WO2008017814A1/en
Priority to EP07789112A priority patent/EP2051713A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GBGB0615814.1A 2006-08-09 2006-08-09 Medicament Ceased GB0615814D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0615814.1A GB0615814D0 (en) 2006-08-09 2006-08-09 Medicament
PCT/GB2007/002963 WO2008017814A1 (en) 2006-08-09 2007-08-03 Prevention and treatment of microbial infection
EP07789112A EP2051713A1 (en) 2006-08-09 2007-08-03 Prevention and treatment of microbial infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0615814.1A GB0615814D0 (en) 2006-08-09 2006-08-09 Medicament

Publications (1)

Publication Number Publication Date
GB0615814D0 true GB0615814D0 (en) 2006-09-20

Family

ID=37056074

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0615814.1A Ceased GB0615814D0 (en) 2006-08-09 2006-08-09 Medicament

Country Status (3)

Country Link
EP (1) EP2051713A1 (en)
GB (1) GB0615814D0 (en)
WO (1) WO2008017814A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2715281T3 (en) * 2012-03-20 2019-06-03 Merial Inc Treatment of microbial infections
CA3169675A1 (en) 2020-01-31 2021-08-05 You First Services, Inc. Methods of making delmopinol and salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894221A (en) 1981-03-19 1990-01-16 Ab Ferrosan Method of treating plaque using morpholine compounds
HU205118B (en) 1989-05-24 1992-03-30 Pharmacia Ab Process for producing new intermediary isoxazolooxazines for the production of delmopinol
US5082653A (en) 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
DE69108711T2 (en) 1990-11-09 1995-11-16 Pharmacia Ab AGENT IMPROVED AGAINST DENTAL COATING CONTAINING A COMBINATION OF A MORPHOLINOAMINO ALCOHOL AND AN ANTIMICROBIAL AGENT.
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
GB0502046D0 (en) 2005-02-01 2005-03-09 Sinclair Pharmaceuticals Ltd Method

Also Published As

Publication number Publication date
WO2008017814A1 (en) 2008-02-14
EP2051713A1 (en) 2009-04-29

Similar Documents

Publication Publication Date Title
GB2436526B (en) Syringe
EP1992348A4 (en) Pharmaceutical combination
GB0620359D0 (en) Medical devices
HUE038232T2 (en) Inhaler
IL195247A0 (en) Inhaler
GB0603926D0 (en) Syringes
ZA200806318B (en) Drug combinations
EP2015810A4 (en) Improved syringe
GB0617134D0 (en) Medical devices
IL197883A0 (en) Combination drug
GB0625783D0 (en) Medicament
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
GB0608046D0 (en) Syringe
GB2434754B (en) Inhaler
GB0615064D0 (en) Medicament
GB0613031D0 (en) Medicaments
AP2006000208S (en) Inhaler
GB0608996D0 (en) Drug counter
GB0615814D0 (en) Medicament
GB0717450D0 (en) Medicament
ZA200809732B (en) Single use syringe
TWM292546U (en) Medicament counter
ZA200708369B (en) Medicament
AU311731S (en) Inhaler
ZA200902756B (en) Combination drug

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)